Literature DB >> 12614359

Transmembrane adapters: attractants for cytoplasmic effectors.

Jonathan A Lindquist1, Luca Simeoni, Burkhart Schraven.   

Abstract

Transmembrane adapter proteins (TRAPs) are a relatively new and growing family of proteins that include linker for activation of T cells (LAT), phosphoprotein associated with glycosphingolipid-enriched micro domains (PAG)/C-terminal Src kinase (Csk) binding protein (Cbp), SHP2-interacting transmembrane adapter protein (SIT), T cell receptor interacting molecule (TRIM), and the recently identified non-T cell activation linker (NTAL) and pp30. TRAPs share several common structural features, but more importantly they possess multiple sites of tyrosine phosphorylation, by which they act as scaffolds for recruiting cytosolic adapter and/or effector proteins. The membrane association of TRAPs places them near to the immunoreceptors, a position from which they coordinate and modulate the signals they receive to produce an appropriate cellular response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614359     DOI: 10.1034/j.1600-065x.2003.00007.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  18 in total

Review 1.  Rethinking the role of Src family protein tyrosine kinases in the allergic response: new insights on the functional coupling of the high affinity IgE receptor.

Authors:  Yasuko Furumoto; Claudia Gonzalez-Espinosa; Gregorio Gomez; Martina Kovarova; Sandra Odom; Valentino Parravicini; John J Ryana; Juan Rivera
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Lck regulates the threshold of activation in primary T cells, while both Lck and Fyn contribute to the magnitude of the extracellular signal-related kinase response.

Authors:  Matthew Lovatt; Andrew Filby; Valentino Parravicini; Guy Werlen; Ed Palmer; Rose Zamoyska
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

Review 3.  mTOR and other effector kinase signals that impact T cell function and activity.

Authors:  Darienne R Myers; Benjamin Wheeler; Jeroen P Roose
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

4.  Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.

Authors:  Paul Van Slyke; Mariano Loza Coll; Zubin Master; Harold Kim; Jorge Filmus; Daniel J Dumont
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 5.  Regulation of lymphocyte development and activation by the LAT family of adapter proteins.

Authors:  Deirdre M Fuller; Weiguo Zhang
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

6.  Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomain.

Authors:  Chitose Oneyama; Takuya Iino; Kazunobu Saito; Kei Suzuki; Akira Ogawa; Masato Okada
Journal:  Mol Cell Biol       Date:  2009-10-12       Impact factor: 4.272

7.  Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts.

Authors:  Takaki Shima; Shigeyuki Nada; Masato Okada
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-25       Impact factor: 11.205

8.  Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells.

Authors:  Marianne Strazza; Inbar Azoulay-Alfaguter; Michael Peled; Kieran Adam; Adam Mor
Journal:  Commun Biol       Date:  2021-06-03

9.  Integrating signals from the T-cell receptor and the interleukin-2 receptor.

Authors:  Tilo Beyer; Mandy Busse; Kroum Hristov; Slavyana Gurbiel; Michal Smida; Utz-Uwe Haus; Kathrin Ballerstein; Frank Pfeuffer; Robert Weismantel; Burkhart Schraven; Jonathan A Lindquist
Journal:  PLoS Comput Biol       Date:  2011-08-04       Impact factor: 4.475

10.  Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity.

Authors:  Nader Omidvar; Eddie C Y Wang; Paul Brennan; M Paula Longhi; Richard A G Smith; B Paul Morgan
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.